Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Public ClinicalTrials.gov record NCT02188160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to determine the efficacy and safety of KPI-121 0.25% ophthalmic suspension compared to vehicle (placebo) in subjects who have a documented clinical diagnosis of dry eye disease. The product will be studied over 28 days, with 1-2 drops instilled in each eye four times daily (QID).
Study identification
- NCT ID
- NCT02188160
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2014
- Primary completion
- Dec 31, 2014
- Completion
- Feb 28, 2015
- Last update posted
- Jan 5, 2021
2014 – 2015
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sall Research Medical Center | Artesia | California | 90701 | — |
| North Valley Eye Medical Group | Mission Hills | California | 91345 | — |
| Martel Eye Medical Group | Rancho Cordova | California | 95670 | — |
| Eye Center of Southern CT, P.C. | Hamden | Connecticut | 06518 | — |
| Price Vision Group | Indianapolis | Indiana | 46260 | — |
| Ophthalmology Associates | St Louis | Missouri | 63131 | — |
| Comprehensive Eye Care, Ltd. / Vision Research Institute, LLC | Washington | Missouri | 63090 | — |
| South Shore Eye Center, LLP | Wantagh | New York | 11793 | — |
| Abrams Eye Center | Cleveland | Ohio | 44115 | — |
| Total Eye Care, PA | Memphis | Tennessee | 38119 | — |
| Whitsett Vision Group | Houston | Texas | 77055 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02188160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 5, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02188160 live on ClinicalTrials.gov.